Get notified of page updates

Categories Cancer Risk

FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.

Search XRAY

reset
reset search

Search Results for Categories Cancer Risk page 1

Showing 1 through 10 out of 129

Relevance: Medium-High

Most relevant for: People who may be at high risk for melanoma

Study: Mutations in familial melanoma genes and cancer risk

Researchers studied nearly 700,000 people from the United States and the United Kingdom to learn how common mutations in familial melanoma genes are in the general population. They found that these mutations may be more common than previously estimated and were often found in people who developed melanoma at a young age or who had more than one melanoma. These findings suggest that some people with melanoma may benefit from discussing genetic counseling and testing with their healthcare provider. (posted 7/28/2026)

READ MORE  ›

Relevance: Medium

Most relevant for: People taking or considering GLP-1 drugs

Study: GLP-1 drugs and breast cancer: results from ASCO 2026

Studies presented at the 2026 ASCO Annual Meeting looked at GLP-1 drugs in relation to breast cancer prevention and survival. Across these early studies, people taking GLP-1s drugs often had better breast cancer outcomes than similar people not taking them. (posted 7/20/2026)

READ MORE  ›

Relevance: Medium-High

Most relevant for: People at high-risk for colorectal cancer

Study: Comparison of GLP-1 drugs and aspirin for colorectal cancer prevention

This study compared aspirin with GLP-1 drugs used for type 2 diabetes and weight loss to see which might better prevent colorectal cancer in people who had not already had colorectal cancer. Researchers found that people who took GLP-1 drugs were less likely to develop colorectal cancer than those who took aspirin.  (posted 6/26/2026)

READ MORE  ›

Relevance: Medium-High

Most relevant for: People with a BRCA1 or BRCA2 mutation who have had ovarian cancer

Study: Breast cancer risk after ovarian cancer in women with BRCA mutations

Women who have an inherited mutation in BRCA1 or BRCA2 have a higher lifetime risk of developing breast and ovarian cancer compared to women without these mutations. This study found that after being diagnosed with ovarian cancer, women with a BRCA1 or BRCA2 mutation have a relatively low risk of developing breast cancer. (posted 5/18/2026)

READ MORE  ›

Relevance: High

Most relevant for: People with a PALB2 mutation

Study: Understanding inherited PALB2 mutations and risk of multiple cancers

Inherited mutations in the PALB2 gene are linked to increased risk of several cancers, including breast, pancreatic, ovarian, and prostate cancers. This study estimates the effect of an inherited PALB2 mutation on a person’s risk of developing each of these cancers. (posted 4/6/2026)

READ MORE  ›

Relevance: Medium-High

Most relevant for: People who have had or are considering liquid biopsy testing

Topic: What Patients Need to Know About Liquid Biopsies in Cancer Care

Liquid biopsies are tests that look for signs of cancer in blood or other body fluids. These signs can include cancer cells that have broken away from a tumor, pieces of cancer cell DNA and proteins or other biomarkers found in cancer cells. Liquid biopsies can be used to screen for cancer before a cancer diagnosis or guide treatment after a diagnosis. (posted 2/6/26)

READ MORE  ›

Relevance: High

Most relevant for: Men and women diagnosed with breast cancer who have a BRCA1 or BRCA2 mutation

Study: Understanding the risks of a second cancer after a breast cancer diagnosis in people with BRCA1 and BRCA2 mutations

After breast cancer, people who have a BRCA1 or BRCA2 mutation face a greater risk of a second cancer compared to individuals without a BRCA mutation. This study helps to better understand this risk so that breast cancer survivors with mutations can receive informed, personalized plans for surveillance and follow-up care. (Posted 12/11/25)

READ MORE  ›

Relevance: Medium

Most relevant for: People concerned about their risk of pancreatic cancer

Study: Bacteria and fungi in the mouth may help identify those at risk for pancreatic cancer

Pancreatic cancer often grows quickly and is usually discovered at a later stage. A better understanding of risk factors, like changes in bacteria found in the mouth, could provide doctors with early warning signs needed to help them diagnose and treat cancer sooner. The results of this study suggest that changes in bacteria and fungi in your mouth may help identify people who are at higher risk of pancreatic cancer. (Posted 11/24/25)

READ MORE  ›

Relevance: Medium-High

Most relevant for: Women with a BRCA1 or BRCA2 mutation who have a uterus.

Study: Endometrial cancer risk for people with BRCA1 and BRCA2 mutations

This study looked at how often endometrial cancer occurred in people with BRCA1 or BRCA2 mutations to better understand how BRCA mutations affect the risk of endometrial cancer. The researchers also asked whether known risk factors for endometrial cancer impact the frequency of endometrial cancer in people with BRCA1 or BRCA2 mutations. Findings from the study highlight the importance of shared conversations between patients and providers regarding risk monitoring and preventive options. (posted 10/7/25)

READ MORE  ›

Relevance: High

Most relevant for: Families with a known MLH1 mutation

Study: Cancer may occur at earlier ages in later generations of families with Lynch syndrome

In families with Lynch syndrome mutations, cancer may occur at an earlier age with each generation. This study looked at the effect called anticipation in families with MLH1-associated Lynch syndrome. (Posted 10/3/25)

READ MORE  ›